| Literature DB >> 28415074 |
Mathurin Dorel1,2,3,4,5,6, Eric Viara7, Emmanuel Barillot1,2,3,4, Andrei Zinovyev1,2,3,4, Inna Kuperstein1,2,3,4.
Abstract
Human diseases such as cancer are routinely characterized by high-throughput molecular technologies, and multi-level omics data are accumulated in public databases at increasing rate. Retrieval and visualization of these data in the context of molecular network maps can provide insights into the pattern of regulation of molecular functions reflected by an omics profile. In order to make this task easy, we developed NaviCom, a Python package and web platform for visualization of multi-level omics data on top of biological network maps. NaviCom is bridging the gap between cBioPortal, the most used resource of large-scale cancer omics data and NaviCell, a data visualization web service that contains several molecular network map collections. NaviCom proposes several standardized modes of data display on top of molecular network maps, allowing addressing specific biological questions. We illustrate how users can easily create interactive network-based cancer molecular portraits via NaviCom web interface using the maps of Atlas of Cancer Signalling Network (ACSN) and other maps. Analysis of these molecular portraits can help in formulating a scientific hypothesis on the molecular mechanisms deregulated in the studied disease. Database URL: NaviCom is available at https://navicom.curie.fr.Entities:
Mesh:
Year: 2017 PMID: 28415074 PMCID: PMC5467574 DOI: 10.1093/database/bax026
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
Figure 1.General architecture of NaviCom. The NaviCom interface provides the user with an updated list of studies from cBioPortal and links to ACSN and NaviCell maps collections. When visualization is requested, NaviCom starts a new NaviCell session and calls a cgi on the server. The cgi downloads cBioPortal data to the NaviCell session and displays them to generate the molecular portrait selected by the user.
Data display settings in NaviCom
| Date type | Visualization mode | Data display | Units |
|---|---|---|---|
| mRNA expression | Map staining | Level | |
| Gene copy number | Heat map | Count | |
| Mutation data | Glyph 1 | Frequency | |
| Methylation data | Glyph 2 | Intensity | |
| miRNA expression | Glyph 3 | Level | |
| Protein expression | Glyph 4 | Level |
Figure 2.Visualization setting panel of NaviCom.
Figure 3.Multi-omics data visualization in Cell Cycle signalling map. Five types of omics data, copy number, expression, methylation, mutations, proteomics, for breast invasive carcinoma dataset from cBioPortal has been displayed on the map using the pre-defined display mode as detailed in Table 1. The values represent average for 825 samples available in the dataset (A) Top level view of data distribution, (B) and (C) Zoom in on individual entities on the map.
Comparison of NaviCom with similar tools
| Feature | Tool | |||||||
|---|---|---|---|---|---|---|---|---|
| REACTOME | Ipath | BioCyc | Pathway projector | FuncTree KEGG PATHWAYS | Cytoscape | NetGestalt | NaviCom | |
| Data fetching | • | • | • | |||||
| Multi-level data display | • | • | • | • | • | |||
| Data display pre-setting | • | • | • | • | • | |||
| Interactive maps | • | • | • | • | • | |||
| Web interface | • | • | • | • | • | • | • | |
| Reference | 7 | 15 | 16 | 17 | 22 | 19 | 18 | |
Figure 4.Molecular portraits of cancer types. Expression and mutation data from cBioPortal has been displayed on the DNA repair map using the pre-defined display mode as detailed in Table 1. The values represent average for all samples available in each dataset (A) acute myeloid leukemia, (B) adenocortical carcinoma (C) ovarian serous cystadenocarcinoma and (D) glioblastoma.
Figure 5.Comparison of base excision repair module regulation in two cancer types. Expression and mutation data from cBioPortal has been displayed on the BER module map using the pre-defined display mode as detailed in Table 1. The values represent average for all samples available in each dataset (A) BER in adenocortical carcinoma (B) Zoom in on initial steps of BER in adenocortical carcinoma, (C) Zoom in on execution step of BER in adenocortical carcinoma, (D) BER in ovarian serous cystadenocarcinoma, (E) Zoom in on initial steps of BER in ovarian serous cystadenocarcinoma, (F) Zoom in on execution step of BER in ovarian serous cystadenocarcinoma.